Skip to main content
. 2019 Nov 22;2019:3518378. doi: 10.1155/2019/3518378

Figure 5.

Figure 5

Expression and prognostic value of CCNB2 in HCC. (a–d) The expression data collected from 3 datasets from ONCOMINE indicated that CCNB2 expression was upregulated in HCC tissues compared with the normal controls (all P < 0.05). (e) Expression of CCNB2 was increased in HCC cells based on the data from CCLE. (f) The Kaplan-Meier survival curves revealed that the high CCNB2 expression predicted worse overall survival compared with the low CCNB2 expression in HCC patients (log-rank P = 0.0013). (g) No significantly different survival times were observed between patients with high CDK1 expression and patients with low CDK1 expression at tumor stage 1 (log-rank P = 0.073). (h) High CCNB2 expression predicted worse overall survival compared with the low CCNB2 expression in HCC patients at tumor stage 2 (log-rank P = 0.022). (i) High CCNB2 expression predicted worse overall survival compared with the low CCNB2 expression in HCC patients at tumor stage 3 (log-rank P = 0.011).